Evidence map›Paper›PMID 38499356›Full record

ArticleLupus science & medicine2024

Concentrations of subcutaneously administered belimumab in human breast milk of a woman with systemic lupus erythematosus: a case report.

Birgit S Blomjous, Marjon A de Boer, Mirjam M van Weissenbruch, Koen C J Laan, Theo Rispens, Alexandre E Voskuyl, Irene E M Bultink

Open access · goldAbstract readCase ReportsLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Lupus science & medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Safety of Drugs in Breastfeeding Women With CKD.Kidney international reports · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Birgit S BlomjousDepartment of Rheumatology and Clinical Immunology, Amsterdam UMC, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands b.blomjous@amsterdamumc.nl.ORCID 0000-0002-1623-3605
Marjon A de BoerDepartment of Obstetrics and Gynecology, Amsterdam UMC, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Mirjam M van WeissenbruchAmsterdam Reproduction & Development, Amsterdam, The Netherlands.
Koen C J LaanDepartment of Rheumatology, Dijklander Ziekenhuis, Hoorn, The Netherlands.
Theo RispensAmsterdam institute for Infection and Immunity, Amsterdam, The Netherlands.
Alexandre E VoskuylDepartment of Rheumatology and Clinical Immunology, Amsterdam UMC, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.ORCID 0000-0002-9699-1827
Irene E M BultinkDepartment of Rheumatology and Clinical Immunology, Amsterdam UMC, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.ORCID 0000-0002-5441-3420
Amsterdam University Medical Centers · NLEmma Kinderziekenhuis · NLRefaja Ziekenhuis · NLSanquin · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Lupus Erythematosus, SystemicAntibodies, Monoclonal, HumanizedFemaleHumansMilk, HumanAntibodies, Monoclonal, HumanizedbelimumabAntibodiesAntirheumatic AgentsLupus Erythematosus, SystemicPharmacokinetics

Identifiers

PMID38499356
PMCPMC10953294
OpenAlexW4392905853

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.